Position in TPST
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8
-$48 QoQ
Shares Held
5
-93.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TPST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $15,763,119,646 across 407 Biotechnology names. TPST ranks #384 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,553,644 | $135,120,415 | |
| 8 | ASND |
Ascendis Pharma A/S
|
539,434 | $123,384,735 |
All Filings in TPST
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8 | 5 | Shares | Defined | 2026-05-13 | |
| 2025-03-31 | $56 | 77 | Shares | Defined | 2025-05-12 | |
| 2023-12-31 | $483 | 110 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1 | 6 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $726 | 313 | Shares | Defined | 2023-05-18 | |
| 2022-03-31 | $446 | 132 | Shares | Defined | 2022-05-11 | |
| 2021-06-30 | $111 | 10 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||